Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy
Abstract
Clear cell carcinoma arising in a cesarean section scar is extremely rare. Due to the rarity of the tumor, treatment strategies still need to be further elucidated. We report a case of a woman with a clear cell carcinoma of 10 cm outside the abdominal cavity in her cesarean section scar. Staging surgery revealed two lymph nodes with metastatic dissemination of a clear cell adenocarcinoma. After staging surgery, six cycles of adjuvant chemotherapy with carboplatin/paclitaxel were performed. The patient was disease-free 10 months after completion of chemotherapy. Comprehensive treatment consisting of radical surgery combined with adjuvant chemotherapy can be considered for this uncommon tumor entity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm.
“Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm [63,64,65,66,67,68,69,70,71,72,73,74].”
From Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review (2024) · cites this paper as [65]
The citation lists haven’t been fetched yet
References 14 · Cited by 14
- Authors
- Aust, S., Tiringer, D., Grimm, C., Stani, J., & Langer, M.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- Medical University of Vienna (AT)
- Corresponding author
- Aust, Stefanie
- Venue
- Wiener klinische Wochenschrift
- Published
- 2014-10-10
- Volume
- 127
- Issue
- 1-2
- Pages
- 62-64
- ISSN
- 0043-5325 (ISSN-L)
- 1613-7671
- OpenAlex
- W160314027
- Cited by
- 14
- References
- 14
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2021: 5 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Wiener klinische Wochenschrift (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Metastasis and carcinoma case studies
- Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
- Keywords
- clear cell adenocarcinoma, cancer of unknown primary, abdominal wall tumor, cesarean section scar, hysterectomy, lymph node metastasis, adjuvant chemotherapy, carboplatin, paclitaxel, radical surgery, rare tumor
- MeSH terms
- Abdominal Neoplasms, Cesarean Section, Female, Humans, Hysterectomy, Middle Aged, Neoplasms, Unknown Primary, Pregnancy, Pregnancy Complications, Neoplastic, Treatment Outcome, Adenocarcinoma, Clear Cell, Abdominal Wall
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
